Ambulatory surgery centers (ASCs) remain one of the most active segments in healthcare transactions. While the market has not seen a sudden surge in activity recently, deal flow has remained steady compared to other areas of healthcare, reflecting continued investor interest in the ASC model—especially with the continued shift toward outpatient care.
Both single-specialty and multi-specialty centers still attract buyers, particularly when they demonstrate strong fundamentals. Specialties like orthopedics, gastroenterology, and retina remain active, while emerging procedural growth in areas like cardiology is beginning to draw additional attention. However, procedural expansion alone does not guarantee rapid adoption; physician alignment and comfort with performing procedures in the ASC setting still play a major role.
Buyers Are More Disciplined
The level of diligence applied to transactions is heightening. Buyers, lenders, and insurers are placing greater scrutiny on operational and financial fundamentals before closing a deal, meaning transactions may take longer to close, but the additional diligence supports the long-term sustainability of the acquired asset.
Buyers are adopting a more exacting approach to clinical and physical plant diligence, prioritizing facilities that maintain ongoing CMS certification without remediation. Detailed reviews, often involving clinical and life-safety experts, can uncover compliance gaps and capital needs within life-safety systems and critical infrastructure. These findings can materially impact valuations—deterring transactions or serving as leverage in negotiations.
Quality assets with strong operational performance, clinical integrity, and sound infrastructure continue to attract interest.
In today’s market, well-run ASCs with consistent utilization, strong physician alignment, and clean financial reporting are likely to generate competitive buyer interest.
Performance Matters, Even When Valuations Remain Stable
ASC valuation multiples have stayed relatively stable overall, with many centers trading around the historical benchmark of 7–8x EBITDA. However, select best-in-class ASCs, especially those with strong strategic demand, have achieved double-digit valuation multiples. Higher-quality platforms with multiple locations, strong utilization, and efficient operations may command higher multiples, while centers facing operational challenges often trade for lower.
Current buyers place greater emphasis on the underlying strength of the business. Clean revenue cycle management (RCM), efficient operations, and reliable patient volumes all play a critical role in determining valuation.
Revenue Cycle Performance Is Critical
Revenue cycle performance is one of the most important factors influencing both valuation and deal success. Strong RCM operations improve cash flow, shorten the cash conversion cycle, and increase EBITDA—the most common metric in ASC valuations.
Conversely, inconsistent collections, bloated accounts receivable, or poorly managed denial processes can significantly affect a center’s financial performance. Efficient RCM operations are one of the most effective defenses an organization has to potentially mitigate reimbursement risk. During diligence, buyers often perform detailed RCM analyses of claims and payment data to validate revenue. RCM audits can uncover the top trending reasons for denial rates, revenue loss from incorrect contract rates, and missed or low pre-date-of-service collections. If collections cannot support reported revenue levels, valuations may be adjusted accordingly.
Improving RCM performance before entering the transaction process can help organizations capture additional revenue, strengthen margins, and improve enterprise value. Neglecting RCM performance may leave money on the table for ASCs selling their practices.
Leadership & Infrastructure Matter
Operational infrastructure plays a major role in buyer confidence. Organizations relying too heavily on a single founder or operator may struggle to demonstrate scalability. ASCs supported by experienced leadership teams and strong operational processes are better positioned to grow and integrate additional locations.
Preparation is essential for organizations seeking premium valuations. Strong teams, disciplined operations, and clear financial visibility indicate a center’s ability to scale successfully.
Physician alignment and long-term sustainability are also critical factors in buyer confidence. Centers with strong physician engagement, clear succession planning, and consistent productivity are better positioned to maintain performance over time. Buyers will closely evaluate whether case volume is concentrated among a few individuals or supported by a broader, stable physician base, and the likelihood of continued contribution from key surgeons. ASCs that demonstrate thoughtful planning around physician recruitment, retention, and productivity tracking signal durability and reduce perceived risk in the transaction.
The Road Ahead for Ambulatory Surgery Center Transactions
Despite broader healthcare market uncertainty, the ASC sector remains resilient. While predicting short-term shifts in valuation multiples is difficult, one principle remains consistent: High-quality assets command the strongest valuations.
Organizations that focus on strengthening operational fundamentals—particularly revenue cycle performance, leadership infrastructure, and physician alignment—will be best positioned to attract investor interest and achieve long-term growth.
Every ASC’s story is different, and so is its value. Reach out to VMG Health to understand your center’s value and position it for a successful transaction.
